Neurocrine Biosciences Inc (NASDAQ:NBIX)

94.08
Delayed Data
As of May 23
 +0.66 / +0.71%
Today’s Change
41.76
Today|||52-Week Range
95.48
+21.25%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gorman Kevin Charles
Chief Executive Officer
Sale5/01/2018126,832$80.75$10.2M+11.48%
Gorman Kevin Charles
Chief Executive Officer
Sale2/06/2018100,000$80.07$8.0M+14.06%
Grigoriadis Dimitri E
Chief Research Officer
Sale2/09/201871,775$77.98$5.6M+18.67%
Bozigian Haig P
Chief Development Officer
Sale3/05/201861,474$90.00$5.5M+4.30%
Obrien Christopher Flint
Chief Medical Officer
Sale11/02/201745,299$69.71$3.2M+29.27%
Obrien Christopher Flint
Chief Medical Officer
Sale9/05/201752,817$57.50$3.0M+62.12%
Grigoriadis Dimitri E
Chief Research Officer
Sale11/08/201730,000$74.58$2.2M+27.05%
Gano Kyle
Chief Business Development Officer
Sale3/05/201823,650$90.00$2.1M+4.30%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale1/02/201818,084$77.52$1.4M+18.64%
Bozigian Haig P
Chief Development Officer
Sale3/05/201814,399$90.00$1.3M+4.30%
Page of 11